2011 annual financial data
Rigel Pharmaceuticals 2011 Operating margin
Direct answer
Operating margin was -1,818.27%.
Operating income was -86,368,000 USD and net income was -85,973,000 USD.
Operating cash flow was -69,375,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,750,000 USD
- Operating income
- -86,368,000 USD
- Net income
- -85,973,000 USD
- Operating cash flow
- -69,375,000 USD